MoonLake Immunotherapeut... News - MLTX

Company Name	Stock Ticker Symbol	Market	Type
MoonLake Immunotherapeutics	MLTX	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	42.43	04:09:55

Open Price	Low Price	High Price	Close Price	Prev Close
				42.43

more quote information »

Recent News

Date	Time	Source	Heading
4/10/2024	07:00	BW	MoonLake Immunotherapeutics Inks Three-Year Technology..
3/11/2024	08:01	EDGAR2	Form 8-K - Current report
3/10/2024	12:00	GLOBE	MoonLake announces significant improvements with Nanobody®..
3/04/2024	08:00	GLOBE	MoonLake Immunotherapeutics to present MIRA trial data of..
2/29/2024	19:56	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/29/2024	19:53	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/29/2024	08:05	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/29/2024	08:03	EDGAR2	Form 8-K - Current report
2/29/2024	08:00	GLOBE	MoonLake Immunotherapeutics Reports Full Year 2023 Financial..
2/26/2024	09:00	EDGAR2	Form 8-K - Current report
2/26/2024	08:00	GLOBE	MoonLake Immunotherapeutics Announces Positive Feedback from..
2/23/2024	16:48	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/22/2024	18:32	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/20/2024	18:36	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/16/2024	18:02	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/15/2024	16:02	EDGAR2	Form 144 - Report of proposed sale of securities
2/15/2024	08:00	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/14/2024	16:05	EDGAR2	Form 144 - Report of proposed sale of securities
12/21/2023	16:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/20/2023	16:16	EDGAR2	Form 144 - Report of proposed sale of securities
12/19/2023	16:34	EDGAR2	Form 144 - Report of proposed sale of securities
11/14/2023	08:00	GLOBE	MoonLake Immunotherapeutics Reports Third Quarter 2023..
11/06/2023	07:55	EDGAR2	Form 8-K - Current report
11/05/2023	11:00	GLOBE	MoonLake Immunotherapeutics announces landmark Phase 2..
10/16/2023	06:16	EDGAR2	Form 8-K - Current report
10/15/2023	09:03	GLOBE	MoonLake Immunotherapeutics announces the full dataset from..
10/11/2023	10:15	GLOBE	MoonLake Immunotherapeutics presents positive 12-week data..
10/04/2023	07:01	GLOBE	Phase 2 MIRA primary analysis trial results (12-week) for..
9/06/2023	07:00	GLOBE	MoonLake Immunotherapeutics to host a Capital Markets Day on..
8/10/2023	07:00	GLOBE	MoonLake Immunotherapeutics Reports Second Quarter 2023..
7/25/2023	08:00	GLOBE	MoonLake completes patient randomization ahead of schedule..
7/17/2023	07:30	IHMARKETNEWS	Monday’s Wall Street Highlights: Microsoft, Santander,..
6/28/2023	05:00	GLOBE	MoonLake Immunotherapeutics Announces Pricing of $400..
6/26/2023	16:01	GLOBE	MoonLake Immunotherapeutics Announces Proposed Underwritten..
6/25/2023	09:00	GLOBE	MoonLake Immunotherapeutics achieves landmark milestone with..
5/12/2023	07:45	GLOBE	MoonLake Immunotherapeutics Reports First Quarter 2023..
5/03/2023	06:45	GLOBE	MoonLake Immunotherapeutics and SHL Medical collaborate to..